SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-19-110870
Filing Date
2019-04-18
Accepted
2019-04-18 16:04:04
Documents
8
Period of Report
2019-05-29
Effectiveness Date
2019-04-18

Document Format Files

Seq Description Document Type Size
1 DEF 14A d685927ddef14a.htm DEF 14A 774148
2 GRAPHIC g685927g11y77.jpg GRAPHIC 26592
3 GRAPHIC g685927g12k22.jpg GRAPHIC 109839
4 GRAPHIC g685927g18r02.jpg GRAPHIC 8555
5 GRAPHIC g685927g21j11.jpg GRAPHIC 24658
6 GRAPHIC g685927g32p61.jpg GRAPHIC 25201
7 GRAPHIC g685927g56z83.jpg GRAPHIC 16586
8 GRAPHIC g685927g57f70.jpg GRAPHIC 22487
  Complete submission text file 0001193125-19-110870.txt   1098183
Mailing Address 88 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 88 SIDNEY STREET CAMBRIDGE MA 02139 617-649-8600
AGIOS PHARMACEUTICALS INC (Filer) CIK: 0001439222 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36014 | Film No.: 19755928
SIC: 2834 Pharmaceutical Preparations